News & Updates

Show Multimedia Only

Low incidence of CV AEs with lasmiditan in migraine

20 Jul 2020 by

Cardiovascular (CV) event incidence was low among patients taking lasmiditan for migraine, according to interim analysis of the phase III GLADIATOR* study presented at AHS 2020.

Low incidence of CV AEs with lasmiditan in migraine

20 Jul 2020

New biomarker may predict dementia early

20 Jul 2020 by

Researchers from the Flinders University in Australia and University of Aberdeen in the UK have found that a biomarker associated with atherosclerosis and cardiovascular disease, asymmetric dimethylarginine (ADMA), is also associated with declining cognitive performance in the elderly.

New biomarker may predict dementia early

20 Jul 2020

Riboflavin may help reduce frequency of paediatric migraine

20 Jul 2020 by

Treatment with riboflavin significantly reduced monthly headache days in children and adolescents with migraine, according to a study presented at AHS 2020.

Riboflavin may help reduce frequency of paediatric migraine

20 Jul 2020

News & Updates

Filter by Specialty:

Specialty:

Low incidence of CV AEs with lasmiditan in migraine

Low incidence of CV AEs with lasmiditan in migraine

New biomarker may predict dementia early

New biomarker may predict dementia early

Riboflavin may help reduce frequency of paediatric migraine

Riboflavin may help reduce frequency of paediatric migraine